封面
市場調查報告書
商品編碼
1454265

非侵入性血糖監測設備市場:按技術、按模式、按最終用戶、按地區。

Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, By Modality, By End User, By Geography .

出版日期: | 出版商: Coherent Market Insights | 英文 163 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年,全球非侵入性血糖監測設備市場價值為2,422萬美元,2024年至2031年年複合成長率(CAGR)為15.7%,預計2031年將達到7,763萬美元。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 2422萬美元
實際資料 2019-2023 預測期 2024-2031
預測期2023/2024~2030/2031年複合成長率: 15.70% 2030/2031 年預測值 7763萬美元
圖 1. 2023 年非侵入性血糖監測設備的全球市場佔有率(按地區分類)
非侵入性血糖監測設備市場-IMG1

非侵入性血糖監測,顧名思義,是指在不損傷人體組織的情況下檢測血糖。與傳統的指尖採血方法相比,非侵入性血糖監測設備提供了一種經濟且無痛的血糖值監測方法。這些設備的工作原理是掃描皮膚附近的血管,而不是抽血。微創微針、近紅外線光譜和超寬頻雷達等葡萄糖檢測技術的進步促進了非侵入性產品的開發,這些產品可以忠實地反映侵入性監測方法的測量結果。這為糖尿病患者管理病情提供了更大的便利性和依從性。非侵入性血糖監測設備依技術可分為電磁波、經皮、光學和酵素血糖監測設備。

市場動態:

非侵入性血糖監測設備市場是由全球糖尿病盛行率不斷上升以及連續血糖監測技術的進步所推動的。許多新參與企業正在帶著新穎的解決方案進入市場,這些解決方案有助於克服現有侵入性技術(例如手指刺穿)的挑戰。然而,與參考方法相比,在實現高精度方面的技術限制、臨床檢驗不足以及監管核准的延遲等因素繼續限制了廣泛普及。也就是說,專注於改進演算法和感測器的持續研究和開發為非侵入性解決方案提供了一個充滿希望的機會,使其成為傳統血糖測試的可行替代方案。

知識和診斷的缺乏預計將阻礙全球非侵入性血糖監測設備市場在預測期內的成長。

本研究的主要特點

  • 該報告對全球非侵入性血糖監測設備市場進行了詳細分析,並提供了以2023年為基準年的預測期(2023-2031年)的市場規模和年複合成長率(CAGR%)。
  • 它闡明了不同細分市場的潛在收益成長機會,並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 它根據公司亮點、產品系列、主要亮點、績效和策略等參數,介紹了全球非侵入性血糖監測設備市場的主要企業。
  • 本研究報告中介紹的主要企業包括Baxter International Inc.、Dexcom, Inc.、Abbott、Medtronic、Senseonics Holdings, Inc.、GlySens Incorporated、DiaMonTech GmbH、Nemaura Medical Inc.、Integrity Applications, Inc.、CNOGA Medical Ltd. 。
  • 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 本研究報告針對該產業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球非侵入性血糖監測設備市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
  • 需要新斯的明的重症肌無力和術後腸阻塞等疾病的盛行率增加
    • 抑制因素
  • 缺乏知識和診斷
    • 機會
  • 獸醫醫學的發展
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章全球非侵入性血糖監測設備市場 - 冠狀病毒(COVID-19)大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章全球非侵入性血糖監測設備市場(按技術)2019-2031

  • 電磁波
  • 經皮的
  • 光學
  • 酵素

第6章 全球非侵入性血糖監測設備市場(按模式),2019-2031

  • 穿戴式的
  • 非配戴式/桌上型
  • 嵌入式裝置

第7章 全球非侵入性血糖監測設備市場,依最終用戶分類,2019-2031

  • 醫院
  • 診所
  • 居家照護環境

第8章2019-2031年全球非侵入性血糖監測設備市場(按地區)

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東和非洲
  • GCC
  • 以色列
  • 其他中東地區
  • 北非
  • 中部非洲
  • 南非

第9章 競爭格局

  • Baxter International Inc.
  • Dexcom, Inc
  • Abbott
  • Medtronic
  • Senseonics Holdings, Inc
  • GlySens Incorporated
  • DiaMonTech GmbH
  • Nemaura Medical Inc.
  • Integrity Applications, Inc.
  • CNOGA Medical Ltd
  • Breath Health, Inc.
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S.

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI1480

The global non-invasive blood glucose monitoring devices market was valued US$ 24.22 Mn in 2023 and is expected to reach US$ 77.63 Mn by 2031 growing at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 24.22 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 15.70% 2030/2031 Value Projection: US$ 77.63 Mn
Figure 1. Global Non-Invasive Blood Glucose Monitoring Devices Market Share (%), by Region, 2023
Non-Invasive Blood Glucose Monitoring Devices Market - IMG1

Non-invasive blood glucose monitoring, as its name implies, refers to the detection of human blood glucose without causing damage to human tissues. Non-invasive blood glucose monitoring devices offer an economical and pain-free method to monitor blood glucose levels compared to traditional finger-pricking methods. These devices work by scanning the blood vessels near the skin instead of drawing blood. Advancement in glucose sensing technologies, such as minimally-invasive micro needles, near infrared spectroscopy, and ultra wideband radar, have facilitated the development of non-invasive products that can closely mirror readings from invasive monitoring methods. This provides diabetics with greater convenience and compliance in managing their condition. Non-invasive blood glucose monitoring devices can be segmented on the basis of technology into EM waves, transdermal, optical, and enzymatic.

Market Dynamics:

The non-invasive blood glucose monitoring devices market is driven by the growing prevalence of diabetes worldwide as well as advancements in continuous glucose monitoring technologies. Many new players are entering the market with novel solutions that can help overcome the challenges with existing invasive methods like finger pricks. However, factors such as technical limitations in achieving high accuracy compared to reference methods, insufficient clinical validation, and slow regulatory approvals continue to restrain widespread adoption. Nonetheless, continued R&D focusing on improved algorithms and sensors offers promising opportunities for non-invasive solutions to become a viable alternative to conventional glucose tests.

Lack of knowledge and diagnosis are expected to hamper the growth of the global non-invasive blood glucose monitoring devices market over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global non-invasive blood glucose monitoring devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global non-invasive blood glucose monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Baxter International Inc., Dexcom, Inc, Abbott, Medtronic, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global non-invasive blood glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-invasive blood glucose monitoring devices market

Detailed Segmentation:

  • Global non-invasive blood glucose monitoring devices Market, By Technology:
    • EM Waves
    • Transdermal
    • Optical
    • Enzymatic
  • Global non-invasive blood glucose monitoring devices Market, By Modality:
    • Wearable
    • Non-wearable/Benchtop
    • Embedded Devices
  • Global non-invasive blood glucose monitoring devices Market, By End User:
    • Hospitals
    • Clinics
    • Homecare setting
  • Global non-invasive blood glucose monitoring devices Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profile:
    • Baxter International Inc.
    • Dexcom, Inc
    • Abbott
    • Medtronic
    • Senseonics Holdings, Inc
    • GlySens Incorporated
    • DiaMonTech GmbH
    • Nemaura Medical Inc.
    • Integrity Applications, Inc.
    • CNOGA Medical Ltd.
    • Breath Health, Inc.
    • Metamaterial Technologies Inc.
    • Opticology Inc.
    • NovioSense BV
    • Quick LLC
    • RSP Systems A/S.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Modality
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
    • Restraints
  • Lack of knowledge and diagnosis
    • Opportunities
  • The growth of veterinary medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Non-Invasive Blood Glucose Monitoring Devices Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • EM Waves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Transdermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Optical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Enzymatic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Modality, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Wearable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Non-wearable/Benchtop
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Embedded Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Non-Invasive Blood Glucose Monitoring Devices Market, By End User, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Homecare setting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Region, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country 2020 -2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub Region, 2019-2031,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dexcom, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Senseonics Holdings, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlySens Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaMonTech GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nemaura Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Integrity Applications, Inc.
  • CNOGA Medical Ltd
  • Breath Health, Inc.
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S.
  • Analyst Views

10. Section

  • Research Methodology
  • About us